Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease
Clinical trial NCT00099242 · COMPLETED
Trial details
- NCT number
- NCT00099242
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-11-01
- Enrollment
- 1040
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.